Cite
Expression of Bcl-2, p53, and MDM2 in Localized Prostate Cancer With Respect to the Outcome of Radical Radiotherapy Dose Escalation
MLA
Vergis, Roy, et al. “Expression of Bcl-2, P53, and MDM2 in Localized Prostate Cancer With Respect to the Outcome of Radical Radiotherapy Dose Escalation.” International Journal of Radiation Oncology, Biology, Physics, vol. 78, no. 1, Sept. 2010, pp. 35–41. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2009.07.1728.
APA
Vergis, R., Corbishley, C. M., Thomas, K., Horwich, A., Huddart, R., Khoo, V., Eeles, R., Sydes, M. R., Cooper, C. S., Dearnaley, D., & Parker, C. (2010). Expression of Bcl-2, p53, and MDM2 in Localized Prostate Cancer With Respect to the Outcome of Radical Radiotherapy Dose Escalation. International Journal of Radiation Oncology, Biology, Physics, 78(1), 35–41. https://doi.org/10.1016/j.ijrobp.2009.07.1728
Chicago
Vergis, Roy, Catherine M. Corbishley, Karen Thomas, Alan Horwich, Robert Huddart, Vincent Khoo, Ros Eeles, et al. 2010. “Expression of Bcl-2, P53, and MDM2 in Localized Prostate Cancer With Respect to the Outcome of Radical Radiotherapy Dose Escalation.” International Journal of Radiation Oncology, Biology, Physics 78 (1): 35–41. doi:10.1016/j.ijrobp.2009.07.1728.